Atea Pharmaceuticals Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | – | – | +622.5% | -45.3% | -100.0% | – | – | |
| – | +0.0% | +223,564.7% | -99.9% | +796.6% | +26,857.7% | +18.9% | -99.5% | |
| – | – | – | +3,211.7% | -100.1% | – | – | – | |
| – | +52.4% | +273.9% | +339.7% | -51.0% | +62.1% | +9.5% | +1.8% | |
| – | +58.4% | +387.6% | +111.6% | +6.4% | +2.5% | -2.1% | -32.7% | |
| – | +54.1% | +48.1% | +884.2% | -38.7% | -28.0% | +16.5% | +65.1% | |
| – | – | – | – | -194.4% | – | – | – | |
| – | – | – | +191.6% | +4,507.9% | – | – | – | |
| – | – | – | – | -186.2% | – | – | – | |
| – | -239.0% | – | – | -120.6% | – | -9.1% | -766.2% | |
| – | – | – | – | -195.6% | – | – | – | |
| – | – | – | – | -194.2% | – | – | – |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.